Publication update – Lung CRUK regimen specific consent forms
I am pleased to inform you that the lung cancer SACT consent forms have been reviewed and updated. They are now available on the CRUK website at : www.cruk.org/sact_consent.
The following new regimens have been added to the list:
- Alectinib
- Atezolizumab, bevacizumab, carboplatin and paclitaxel
- Atezolizumab, carboplatin and etoposide
- Brigatinib
- Carboplatin, pemetrexed and pembrolizumab
- Carboplatin, paclitaxel and pembrolizumab
- Cisplatin, pemetrexed and pembrolizumab
- Dacomitinib
- Durvalumab
- Larotrectinib
- Lorlatinib
- Selpercatinib
- Sotorasib
Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.
Any questions, please do let me know.
Best wishes,
Alia Nizam, Specialist Oncology Pharmacist. CRUK – Information Lead
Guy’s and St Thomas’ NHS Foundation Trust
